Literature DB >> 116289

Modification of spontaneous ECoG and behavior in cat by monoamine precursors.

J J Bouyer, L Dedet, J P Joseph, A Rougeul.   

Abstract

The effects of increasing the brain monoamine content on the three types of localized rhythms identified in somatic area I ("mu-type rhythms") were studied in freely moving cats. Increases in brain monoamines (catecholamines and serotonin) were produced by injecting L-Dopa and 5-HTP, L-tyrosine, L-tryptophan and tryptamine were also tested. It is concluded that the two subsets of rhythms, one accompanying high levels of alertness and vigilance and the other appearing during quiet wakefulness, are related to the catecholaminergic systems, while those characterizing drowsiness seem to be controlled by a serotoninergic system. The latter, however, is distinct from that controlling slow sleep.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116289     DOI: 10.1007/bf00491977

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Dose-response relationships between systemically administered L-tryptophan or L-5-hydroxytryptophan and raphe unit activity in the rat.

Authors:  M E Trulson; B L Jacobs
Journal:  Neuropharmacology       Date:  1976-06       Impact factor: 5.250

2.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. II. EXPERIMENTALLY INDUCED CHANGES IN THE INTRANEURONAL AMINE LEVELS OF BULBOSPINAL NEURON SYSTEMS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

3.  Evidence that the loss of brain catecholamine stores due to blockade of storage does not cause sedation.

Authors:  G L GESSA; E COSTA; R KUNTZMAN; B B BRODIE
Journal:  Life Sci (1962)       Date:  1962-11

4.  Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.

Authors:  H WEIL-MALHERBE; H S POSNER; G R BOWLES
Journal:  J Pharmacol Exp Ther       Date:  1961-06       Impact factor: 4.030

5.  On the distribution in brain of monoamines and of enzymes responsible for their formation.

Authors:  A BERTLER; E ROSENGREN
Journal:  Experientia       Date:  1959-10-15

6.  The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.

Authors:  S M HESS; B G REDFIELD; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

7.  Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines.

Authors:  W Lichtensteiger; U Mutzner; H Langemann
Journal:  J Neurochem       Date:  1967-05       Impact factor: 5.372

8.  Evidence for a direct action of monamines on the chick central nervous system.

Authors:  C E Spooner; W D Winters
Journal:  Experientia       Date:  1965-05-15

9.  The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain.

Authors:  C M McKean; D E Boggs; N A Peterson
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

10.  Daily fluctuation (circadian and ultradian) in biogenic amines of the rat brain.

Authors:  L E Scheving; W H Harrison; P Gordon; J E Pauly
Journal:  Am J Physiol       Date:  1968-01
View more
  3 in total

1.  Genes of the dopaminergic system selectively modulate top-down but not bottom-up attention.

Authors:  Katja Kerstin Schneider; Andrea B Schote; Jobst Meyer; Christian Frings
Journal:  Cogn Affect Behav Neurosci       Date:  2015-03       Impact factor: 3.282

2.  Effects of two neuroleptic drugs on focal somatoparietal rhythms in free awake cats.

Authors:  J J Bouyer; J P Joseph; A Rougeul
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

3.  Long-term effects of a tryptophan-free diet on serotonin metabolism and sleep-waking balance in rats.

Authors:  J Lanoir; J P Ternaux; C Pons; J M Lagarde
Journal:  Exp Brain Res       Date:  1981       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.